You are here

Home

Clinical Trials: Skin Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, December 15, 2021 - 12:00
Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa
Condition:   Dystrophic Epidermolysis Bullosa
Interventions:   Biological: ALLO-ASC-SHEET;   Other: Vehicle Control
Sponsor:   Anterogen Co., Ltd.
Not yet recruiting
Posted: Wednesday, December 15, 2021 - 12:00
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Skin Ulcer
Condition:   Skin Ulcer
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Posted: Monday, November 15, 2021 - 12:00
A Novel Therapeutic Treatment of Pyoderma Gangrenosum
Condition:   Pyoderma Gangrenosum
Intervention:   Biological: Dehydrated human amnion/chorion membrane
Sponsor:   Louisiana State University Health Sciences Center in New Orleans
Recruiting
Posted: Monday, November 8, 2021 - 12:00
Open-label, Pivotal Clinical Trial to Confirm Efficacy and Safety of Autologous Grafts Containing Stem Cells Genetically Modified for Epidermis Restoration in Patients With Junctional Epidermolysis Bullosa
Condition:   Junctional Epidermolysis Bullosa Non-Herlitz Type
Intervention:   Drug: Transplantation
Sponsors:   Holostem Terapie Avanzate s.r.l.;   IRCCS San Raffaele;   University of Modena and Reggio Emilia
Not yet recruiting
Posted: Thursday, October 28, 2021 - 12:00
A Safety and Efficacy Study of FCR001 in Adults With Rapidly Progressive Diffuse Cutaneous Systemic Sclerosis
Condition:   Diffuse Cutaneous Systemic Sclerosis
Intervention:   Biological: FCR001
Sponsor:   Talaris Therapeutics Inc.
Not yet recruiting
Posted: Friday, October 8, 2021 - 12:00
Effectiveness of the Autologous Adipose Tissue Harvested With SEFFICARE Method for Treatment of DFU Minor Amputation
Conditions:   Diabetic Foot;   Diabetic Foot Ulcer;   Amputation
Intervention:   Device: SEFFICARE
Sponsors:   Azienda Ospedaliero-Universitaria di Modena;   University of Modena and Reggio Emilia
Not yet recruiting
Posted: Monday, August 23, 2021 - 12:00
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis
Condition:   Systemic Sclerosis
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Posted: Friday, August 13, 2021 - 12:00
Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD)
Condition:   Dermatitis, Atopic
Interventions:   Biological: FURESTEM-AD® inj. 5.0 X 10^7 cells/1.5 mL;   Biological: Placebo
Sponsor:   Kang Stem Biotech Co., Ltd.
Recruiting
Posted: Monday, July 26, 2021 - 12:00
Evaluate the Safety, Tolerability and Efficacy of PN-101 in Patients With Refractory Polymyositis or Dermatomyositis
Conditions:   Polymyositis;   Dermatomyositis
Intervention:   Biological: PN-101
Sponsor:   Paean Biotechnology Inc.
Not yet recruiting
Posted: Wednesday, July 21, 2021 - 12:00
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)
Condition:   Skin Ulcer Venous Stasis Chronic
Interventions:   Biological: allo-APZ2-CVU;   Drug: Placebo
Sponsors:   RHEACELL GmbH & Co. KG;   FGK Clinical Research GmbH;   Ticeba GmbH
Not yet recruiting

Pages